Predictive accuracy of the <scp>ASIG</scp> algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension-Reference-Cited by-同舟云学术

Predictive accuracy of the ASIG algorithm in a prospective systemic sclerosis cohort undergoing annual screening for pulmonary arterial hypertension

Published:2024-08-13 Issue:9 Volume:54 Page:1561-1566
ISSN:1444-0903
Container-title:Internal Medicine Journal
language:en
Short-container-title:Internal Medicine Journal

Author:

Brown Zoe¹²^ORCID,Morrisroe Kathleen¹²,Hansen Dylan²,Stevens Wendy²,Proudman Susanna³⁴,Teng Gim G.⁵,Low Andrea⁶⁷,Nikpour Mandana¹²

Affiliation:

1. Department of Medicine The University of Melbourne at St Vincent's Hospital Melbourne Victoria Australia

2. Department of Rheumatology St Vincent's Hospital (Melbourne) Melbourne Victoria Australia

3. Rheumatology Unit Royal Adelaide Hospital Adelaide South Australia Australia

4. Discipline of Medicine University of Adelaide Adelaide South Australia Australia

5. Department of Medicine, Division of Rheumatology Alexandra Hospital, National University Health System Singapore

6. Department of Rheumatology and Immunology Singapore General Hospital Singapore

7. Duke National University of Singapore Singapore

Abstract

AbstractThe Australian Scleroderma Interest Group (ASIG) algorithm for screening pulmonary arterial hypertension (PAH) in systemic sclerosis (SSc) requires only respiratory function tests and serum N‐terminal pro‐brain natriuretic peptide as first‐tier tests, and is recommended in international guidelines. In this communication, we present the findings of the application of the ASIG screening algorithm to a Singaporean cohort undergoing prospective annual screening for PAH, which shows a high negative predictive value. The ASIG algorithm may offer an alternative to more complex and costly SSc‐PAH screening algorithms.

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/imj.16468

Reference18 articles.

1. Early Mortality in a Multinational Systemic Sclerosis Inception Cohort

2. What have multicentre registries across the world taught us about the disease features of systemic sclerosis?

3. Epidemiology and disease characteristics of systemic sclerosis-related pulmonary arterial hypertension: results from a real-life screening programme

4. Diagnosis of pulmonary hypertension

5. ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension;Humbert M;Eur Respir J,2022